SquareMind, a medical robotics company based in France, has successfully secured $18 million in funding, which includes previously undisclosed pre-Series A financing. This investment, primarily led by Sonder Capital, a California-based venture fund co-founded by Fred Moll, comes as SquareMind gears up to launch its innovative robotic skin imaging platform aimed at dermatology practices. The company plans to introduce this technology in both the United States and Europe, enhancing diagnostic capabilities in the field. The funding will support the final stages of development and facilitate the market entry of this cutting-edge solution, addressing the growing demand for advanced dermatological tools.
Leave a comment